KRAS and neoplasm: Our findings explain how the tumor microenvironment fuels tumor NF-κΒ activity56 and link the pro-tumorigenic functions of IL-1β with KRAS mutations, setting a rationale for genotype-stratified future investigations on IL-1β functions and therapies in cancer.